Track topics on Twitter Track topics that are important to you
Tokio (ots/PRNewswire) - Mogamulizumab wäre nach Zulassung der erste biologische Wirkstoff gegen CCR4 für Patienten in Europa. Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin), hat heute bekanntgegeben, ....
Tokyo, Japan, May 30, 2018 –Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151 President and COO: Masashi Miyamoto, “Kyowa Hakko Kirin”) announced today that it has been notified that the U.S. Food and Dr...
The European Commission has approved Poteligeo (mogamulizumab), a treatment for rare types of non-Hodgkin’s lymphoma. The drug is manufactured by Japanese firm Kyowa Hakko Kirin (Kyowa Kirin), and ...
Tokyo (ots/PRNewswire) - POTELIGEO will be the first biologic agent targeting CCR4 to be available for patients in Europe. Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces today that it has rec...
TOKYO, Aug. 8, 2018 /PRNewswire/ — Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces today that the U.S. Food and Drug Administration (FDA) has granted approval for Poteligeo® (mogamulizumab...
Ultragenyx Pharmaceutical (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, Kyowa Hakko Kirin and Kyowa Kirin In...
The US Food and Drug Administration (FDA) has granted approval to biotechnology company Kyowa Kirin’s Poteligeo (mogamulizumab-kpkc) injection to treat...Read More... The post FDA approves Kyowa...
Kyowa Hakko Kirin Co., Ltd. Strategy, SWOT and Corporate Finance ReportSummaryKyowa Hakko Kirin Co., Ltd. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and i...
Brewery liquid waste (BLW), brewery spent grain (BSG), apple pomace solid wastes (APS), apple pomace ultrafiltration sludge (APUS) and starch industry waste (SIW) were evaluated as alternative feedsto...
Lactobacillus (L.) brevis represents a versatile, ubiquitistic species of lactic acid bacteria, occurring in various foods, as well as plants and intestinal tracts. The ability to deal with considerab...
The Student-t-test, one of the most used statistical tests in medicine, was developed by a beer brewer. From around 1900, the Irish Guinness brewery started recruiting scientists for the position of b...
Xylanases play a crucial role in the hydrolysis of xylan-rich hemicelluloses and have wide industrial applications in the fuel, food, feed and pulp and paper industries. The production of these enzyme...
Genetic diversity often enhances the tolerance of microbial communities against antimicrobial treatment. However the sociobiology underlying this antimicrobial tolerance remains largely unexplored. He...
Hematech, LLC was founded in 1998 and has its corporate headquarters in Sioux Falls, SD. In 1999, Hematech and the Pharmaceutical Division of the Kirin Brewery Company began a research collaboration t...
We have published hundreds of Kirin Brewery Co.,LTD news stories on BioPortfolio along with dozens of Kirin Brewery Co.,LTD Clinical Trials and PubMed Articles about Kirin Brewery Co.,LTD for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kirin Brewery Co.,LTD Companies in our database. You can also find out about relevant Kirin Brewery Co.,LTD Drugs and Medications on this site too.